<?xml version="1.0" encoding="UTF-8"?>

<ConceptMap xmlns="http://hl7.org/fhir">
  <id value="ch-vacd-immunoglobulin-targetdiseases-cm"/>
  <text>
    <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: ConceptMap ch-vacd-immunoglobulin-targetdiseases-cm</b></p><a name="ch-vacd-immunoglobulin-targetdiseases-cm"> </a><a name="hcch-vacd-immunoglobulin-targetdiseases-cm"> </a><p>Mapping from <a href="ValueSet-ch-vacd-swissmedic-immunoglobulin-vs.html">CH VACD Swissmedic Authorized Immunoglobulin Codes</a> to <a href="ValueSet-ch-vacd-targetdiseasesandillnessesundergoneforimmunization-vs.html">CH VACD Target disease and illnesses undergone for immunization</a></p><br/><p><b>Group 1 </b>Mapping from <a href="CodeSystem-ch-vacd-swissmedic-immunoglobulin-cs.html">CH VACD Swissmedic Authorized Immunoglobulin Codes</a> to <a href="http://hl7.org/fhir/R4/codesystem-snomedct.html">SNOMED CT (all versions)</a></p><table class="grid"><tr><td colspan="2"><b>Source Concept Details</b></td><td><b>Relationship</b></td><td colspan="2"><b>Target Concept Details</b></td></tr><tr><td colspan="2"><b>Codes</b> from <a href="CodeSystem-ch-vacd-swissmedic-immunoglobulin-cs.html" title="http://fhir.ch/ig/ch-vacd/CodeSystem/ch-vacd-swissmedic-immunoglobulin-cs">CH VACD Swissmedic Authorized Immunoglobulin Codes</a></td><td/><td colspan="2"><b>Codes</b> from <a href="http://hl7.org/fhir/R4/codesystem-snomedct.html" title="http://snomed.info/sct">SNOMED CT (all versions)</a></td></tr><tr><td style="border-right-width: 0px">00687-01</td><td style="border-left-width: 0px">Berirab 2 ml, Injektionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">14168008</td><td style="border-left-width: 0px">Rabies (disorder)</td></tr><tr><td style="border-right-width: 0px">00687-02</td><td style="border-left-width: 0px">Berirab 5 ml, Injektionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">14168008</td><td style="border-left-width: 0px">Rabies (disorder)</td></tr><tr><td style="border-right-width: 0px">69039-02</td><td style="border-left-width: 0px">Beyfortus 100 mg/1 ml, solution injectable en seringue préremplie</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">55735004</td><td style="border-left-width: 0px">Respiratory syncytial virus infection (disorder)</td></tr><tr><td style="border-right-width: 0px">69039-01</td><td style="border-left-width: 0px">Beyfortus 50 mg/0.5 ml, solution injectable en seringue préremplie</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">55735004</td><td style="border-left-width: 0px">Respiratory syncytial virus infection (disorder)</td></tr><tr><td style="border-right-width: 0px; border-bottom-style: none">68222-01</td><td style="border-left-width: 0px; border-bottom-style: none">Cutaquig 165 mg/ml, Injektionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">58606001</td><td style="border-left-width: 0px">Primary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-top-style: none"/><td style="border-top-style: none; border-left-width: 0px"/><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">33286000</td><td style="border-left-width: 0px">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-bottom-style: none">65992-01</td><td style="border-left-width: 0px; border-bottom-style: none">Cuvitru 200 mg/ml, Injektionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">58606001</td><td style="border-left-width: 0px">Primary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-top-style: none"/><td style="border-top-style: none; border-left-width: 0px"/><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">33286000</td><td style="border-left-width: 0px">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px">00506-02</td><td style="border-left-width: 0px">Cytotect CP Biotest, Infusionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">28944009</td><td style="border-left-width: 0px">Infection caused by Cytomegalovirus (disorder)</td></tr><tr><td style="border-right-width: 0px; border-bottom-style: none">00701-02</td><td style="border-left-width: 0px; border-bottom-style: none">Gammanorm, Injektionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">58606001</td><td style="border-left-width: 0px">Primary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-top-style: none"/><td style="border-top-style: none; border-left-width: 0px"/><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">16318001000119107</td><td style="border-left-width: 0px">Hypogammaglobulinemia due to multiple myeloma (disorder)</td></tr><tr><td style="border-right-width: 0px">00668-01</td><td style="border-left-width: 0px">Gamunex 10%, solution pour injection intraveineuse</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">14189004</td><td style="border-left-width: 0px">Measles (disorder)</td></tr><tr><td style="border-right-width: 0px">00488-02</td><td style="border-left-width: 0px">Hepatect CP, Infusionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">66071002</td><td style="border-left-width: 0px">Viral hepatitis type B (disorder)</td></tr><tr><td style="border-right-width: 0px">00674-01</td><td style="border-left-width: 0px">Hepatitis-B-Immunglobulin Behring, Injektionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">66071002</td><td style="border-left-width: 0px">Viral hepatitis type B (disorder)</td></tr><tr><td style="border-right-width: 0px; border-bottom-style: none">66410-01</td><td style="border-left-width: 0px; border-bottom-style: none">Hizentra 200mg/ml, Injektionslösung zur s.c. Anwendung, Fertigspritze</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">58606001</td><td style="border-left-width: 0px">Primary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-top-style: none"/><td style="border-top-style: none; border-left-width: 0px"/><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">33286000</td><td style="border-left-width: 0px">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-bottom-style: none">61547-01</td><td style="border-left-width: 0px; border-bottom-style: none">Hizentra, Injektionslösung zur s.c. Anwendung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">58606001</td><td style="border-left-width: 0px">Primary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-top-style: none"/><td style="border-top-style: none; border-left-width: 0px"/><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">33286000</td><td style="border-left-width: 0px">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-bottom-style: none">66684-01</td><td style="border-left-width: 0px; border-bottom-style: none">HyQvia 100 mg/ml, Infusionslösung zur subkutanen Anwendung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">58606001</td><td style="border-left-width: 0px">Primary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-top-style: none"/><td style="border-top-style: none; border-left-width: 0px"/><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">33286000</td><td style="border-left-width: 0px">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-bottom-style: none">58157-01</td><td style="border-left-width: 0px; border-bottom-style: none">Ig Vena Kedrion 50 g/I, solution pour infusion</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">58606001</td><td style="border-left-width: 0px">Primary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-top-style: none"/><td style="border-top-style: none; border-left-width: 0px"/><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">33286000</td><td style="border-left-width: 0px">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-bottom-style: none">62913-01</td><td style="border-left-width: 0px; border-bottom-style: none">Intratect 10%, Infusionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">58606001</td><td style="border-left-width: 0px">Primary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-top-style: none"/><td style="border-top-style: none; border-left-width: 0px"/><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">33286000</td><td style="border-left-width: 0px">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-bottom-style: none">57676-01</td><td style="border-left-width: 0px; border-bottom-style: none">Intratect 5%, Infusionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">58606001</td><td style="border-left-width: 0px">Primary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-top-style: none"/><td style="border-top-style: none; border-left-width: 0px"/><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">33286000</td><td style="border-left-width: 0px">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-bottom-style: none">66332-03</td><td style="border-left-width: 0px; border-bottom-style: none">Iqymune 10g/100ml, Infusionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">58606001</td><td style="border-left-width: 0px">Primary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-top-style: none"/><td style="border-top-style: none; border-left-width: 0px"/><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">33286000</td><td style="border-left-width: 0px">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-bottom-style: none">66332-04</td><td style="border-left-width: 0px; border-bottom-style: none">Iqymune 20g/200ml, Infusionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">58606001</td><td style="border-left-width: 0px">Primary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-top-style: none"/><td style="border-top-style: none; border-left-width: 0px"/><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">33286000</td><td style="border-left-width: 0px">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-bottom-style: none">66332-01</td><td style="border-left-width: 0px; border-bottom-style: none">Iqymune 2g/20ml, Infusionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">58606001</td><td style="border-left-width: 0px">Primary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-top-style: none"/><td style="border-top-style: none; border-left-width: 0px"/><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">33286000</td><td style="border-left-width: 0px">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-bottom-style: none">66332-02</td><td style="border-left-width: 0px; border-bottom-style: none">Iqymune 5g/50ml, Infusionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">58606001</td><td style="border-left-width: 0px">Primary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-top-style: none"/><td style="border-top-style: none; border-left-width: 0px"/><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">33286000</td><td style="border-left-width: 0px">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-bottom-style: none">57469-01</td><td style="border-left-width: 0px; border-bottom-style: none">Kiovig, Infusionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">58606001</td><td style="border-left-width: 0px">Primary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-top-style: none"/><td style="border-top-style: none; border-left-width: 0px"/><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">33286000</td><td style="border-left-width: 0px">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-bottom-style: none">60323-01</td><td style="border-left-width: 0px; border-bottom-style: none">Octagam 10 %, Lösung zur intravenösen Anwendung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">58606001</td><td style="border-left-width: 0px">Primary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-top-style: none"/><td style="border-top-style: none; border-left-width: 0px"/><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">33286000</td><td style="border-left-width: 0px">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-bottom-style: none">58314-01</td><td style="border-left-width: 0px; border-bottom-style: none">Privigen, Infusionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">58606001</td><td style="border-left-width: 0px">Primary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-top-style: none"/><td style="border-top-style: none; border-left-width: 0px"/><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">33286000</td><td style="border-left-width: 0px">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px">53609-02</td><td style="border-left-width: 0px">Rhophylac 300, Injektionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">165746003</td><td style="border-left-width: 0px">RhD negative (finding)</td></tr><tr><td style="border-right-width: 0px">65695-02</td><td style="border-left-width: 0px">Synagis 100 mg/1 ml, Injektionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">55735004</td><td style="border-left-width: 0px">Respiratory syncytial virus infection (disorder)</td></tr><tr><td style="border-right-width: 0px">65695-01</td><td style="border-left-width: 0px">Synagis 50 mg/0.5 ml, Injektionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">55735004</td><td style="border-left-width: 0px">Respiratory syncytial virus infection (disorder)</td></tr><tr><td style="border-right-width: 0px">00673-02</td><td style="border-left-width: 0px">Tetagam P, Injektionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">76902006</td><td style="border-left-width: 0px">Tetanus (disorder)</td></tr><tr><td style="border-right-width: 0px">59374-01</td><td style="border-left-width: 0px">Uman Big 180 UI/1 ml, solution pour injection intramusculaire</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">66071002</td><td style="border-left-width: 0px">Viral hepatitis type B (disorder)</td></tr><tr><td style="border-right-width: 0px">59374-02</td><td style="border-left-width: 0px">Uman Big 540 UI/3 ml, solution pour injection intramusculaire</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">66071002</td><td style="border-left-width: 0px">Viral hepatitis type B (disorder)</td></tr><tr><td style="border-right-width: 0px">59451-01</td><td style="border-left-width: 0px">Varitect CP, Lösung zur intravenösen Injektion</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">38907003</td><td style="border-left-width: 0px">Varicella (disorder)</td></tr><tr><td style="border-right-width: 0px">59373-02</td><td style="border-left-width: 0px">Venbig 2500 U.I/50 ml, poudre et solution pour injection intraveineuse</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">66071002</td><td style="border-left-width: 0px">Viral hepatitis type B (disorder)</td></tr><tr><td style="border-right-width: 0px">59373-01</td><td style="border-left-width: 0px">Venbig 500 U.I/10 ml, poudre et solution pour injection intraveineuse</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">66071002</td><td style="border-left-width: 0px">Viral hepatitis type B (disorder)</td></tr><tr><td style="border-right-width: 0px">68471-01</td><td style="border-left-width: 0px">Xevudy, Konzentrat zur Herstellung einer Infusionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">840539006</td><td style="border-left-width: 0px">Disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)</td></tr><tr><td style="border-right-width: 0px">66344-01</td><td style="border-left-width: 0px">Zinplava, Konzentrat zur Herstellung einer Infusionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">56688005</td><td style="border-left-width: 0px">Clostridial infection (disorder)</td></tr><tr><td style="border-right-width: 0px">61639-01</td><td style="border-left-width: 0px">Zutectra, Injektionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">66071002</td><td style="border-left-width: 0px">Viral hepatitis type B (disorder)</td></tr></table></div>
  </text>
  <url value="http://fhir.ch/ig/ch-vacd/ConceptMap/ch-vacd-immunoglobulin-targetdiseases-cm"/>
  <version value="3.3.0"/>
  <name value="ImmunGlobulineToTargetDiseaseMapping"/>
  <title value="ImmunGlobuline To TargetDisease Mapping"/>
  <status value="active"/>
  <experimental value="false"/>
  <date value="2025-12-15T10:47:47+00:00"/>
  <publisher value="HL7 Switzerland"/>
  <contact>
    <name value="HL7 Switzerland"/>
    <telecom>
      <system value="url"/>
      <value value="https://www.hl7.ch/"/>
    </telecom>
  </contact>
  <contact>
    <name value="HL7 Switzerland"/>
    <telecom>
      <system value="url"/>
      <value value="https://www.hl7.ch/"/>
      <use value="work"/>
    </telecom>
  </contact>
  <description value="Mappings from ImmunGlobuline to TargetDisease according to the correcsponding valuesets"/>
  <jurisdiction>
    <coding>
      <system value="urn:iso:std:iso:3166"/>
      <code value="CH"/>
    </coding>
  </jurisdiction>
  <copyright value="This artefact includes content from SNOMED Clinical Terms® (SNOMED CT®) which is copyright of the International Health Terminology Standards Development Organisation (IHTSDO). Implementers of these artefacts must have the appropriate SNOMED CT Affiliate license - for more information contact http://www.snomed.org/snomed-ct/getsnomed-ct or info@snomed.org."/>
  <sourceUri value="http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-swissmedic-immunoglobulin-vs"/>
  <targetUri value="http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-targetdiseasesandillnessesundergoneforimmunization-vs"/>
  <group>
    <source value="http://fhir.ch/ig/ch-vacd/CodeSystem/ch-vacd-swissmedic-immunoglobulin-cs"/>
    <target value="http://snomed.info/sct"/>
    <element>
      <code value="00687-01"/>
      <display value="Berirab 2 ml, Injektionslösung"/>
      <target>
        <code value="14168008"/>
        <display value="Rabies (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
    </element>
    <element>
      <code value="00687-02"/>
      <display value="Berirab 5 ml, Injektionslösung"/>
      <target>
        <code value="14168008"/>
        <display value="Rabies (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
    </element>
    <element>
      <code value="69039-02"/>
      <display value="Beyfortus 100 mg/1 ml, solution injectable en seringue préremplie"/>
      <target>
        <code value="55735004"/>
        <display value="Respiratory syncytial virus infection (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
    </element>
    <element>
      <code value="69039-01"/>
      <display value="Beyfortus 50 mg/0.5 ml, solution injectable en seringue préremplie"/>
      <target>
        <code value="55735004"/>
        <display value="Respiratory syncytial virus infection (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
    </element>
    <element>
      <code value="68222-01"/>
      <display value="Cutaquig 165 mg/ml, Injektionslösung"/>
      <target>
        <code value="58606001"/>
        <display value="Primary immune deficiency disorder (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
      <target>
        <code value="33286000"/>
        <display value="Secondary immune deficiency disorder (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
    </element>
    <element>
      <code value="65992-01"/>
      <display value="Cuvitru 200 mg/ml, Injektionslösung"/>
      <target>
        <code value="58606001"/>
        <display value="Primary immune deficiency disorder (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
      <target>
        <code value="33286000"/>
        <display value="Secondary immune deficiency disorder (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
    </element>
    <element>
      <code value="00506-02"/>
      <display value="Cytotect CP Biotest, Infusionslösung"/>
      <target>
        <code value="28944009"/>
        <display value="Infection caused by Cytomegalovirus (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
    </element>
    <element>
      <code value="00701-02"/>
      <display value="Gammanorm, Injektionslösung"/>
      <target>
        <code value="58606001"/>
        <display value="Primary immune deficiency disorder (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
      <target>
        <code value="16318001000119107"/>
        <display value="Hypogammaglobulinemia due to multiple myeloma (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
    </element>
    <element>
      <code value="00668-01"/>
      <display value="Gamunex 10%, solution pour injection intraveineuse"/>
      <target>
        <code value="14189004"/>
        <display value="Measles (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
    </element>
    <element>
      <code value="00488-02"/>
      <display value="Hepatect CP, Infusionslösung"/>
      <target>
        <code value="66071002"/>
        <display value="Viral hepatitis type B (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
    </element>
    <element>
      <code value="00674-01"/>
      <display value="Hepatitis-B-Immunglobulin Behring, Injektionslösung"/>
      <target>
        <code value="66071002"/>
        <display value="Viral hepatitis type B (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
    </element>
    <element>
      <code value="66410-01"/>
      <display value="Hizentra 200mg/ml, Injektionslösung zur s.c. Anwendung, Fertigspritze"/>
      <target>
        <code value="58606001"/>
        <display value="Primary immune deficiency disorder (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
      <target>
        <code value="33286000"/>
        <display value="Secondary immune deficiency disorder (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
    </element>
    <element>
      <code value="61547-01"/>
      <display value="Hizentra, Injektionslösung zur s.c. Anwendung"/>
      <target>
        <code value="58606001"/>
        <display value="Primary immune deficiency disorder (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
      <target>
        <code value="33286000"/>
        <display value="Secondary immune deficiency disorder (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
    </element>
    <element>
      <code value="66684-01"/>
      <display value="HyQvia 100 mg/ml, Infusionslösung zur subkutanen Anwendung"/>
      <target>
        <code value="58606001"/>
        <display value="Primary immune deficiency disorder (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
      <target>
        <code value="33286000"/>
        <display value="Secondary immune deficiency disorder (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
    </element>
    <element>
      <code value="58157-01"/>
      <display value="Ig Vena Kedrion 50 g/I, solution pour infusion"/>
      <target>
        <code value="58606001"/>
        <display value="Primary immune deficiency disorder (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
      <target>
        <code value="33286000"/>
        <display value="Secondary immune deficiency disorder (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
    </element>
    <element>
      <code value="62913-01"/>
      <display value="Intratect 10%, Infusionslösung"/>
      <target>
        <code value="58606001"/>
        <display value="Primary immune deficiency disorder (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
      <target>
        <code value="33286000"/>
        <display value="Secondary immune deficiency disorder (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
    </element>
    <element>
      <code value="57676-01"/>
      <display value="Intratect 5%, Infusionslösung"/>
      <target>
        <code value="58606001"/>
        <display value="Primary immune deficiency disorder (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
      <target>
        <code value="33286000"/>
        <display value="Secondary immune deficiency disorder (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
    </element>
    <element>
      <code value="66332-03"/>
      <display value="Iqymune 10g/100ml, Infusionslösung"/>
      <target>
        <code value="58606001"/>
        <display value="Primary immune deficiency disorder (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
      <target>
        <code value="33286000"/>
        <display value="Secondary immune deficiency disorder (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
    </element>
    <element>
      <code value="66332-04"/>
      <display value="Iqymune 20g/200ml, Infusionslösung"/>
      <target>
        <code value="58606001"/>
        <display value="Primary immune deficiency disorder (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
      <target>
        <code value="33286000"/>
        <display value="Secondary immune deficiency disorder (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
    </element>
    <element>
      <code value="66332-01"/>
      <display value="Iqymune 2g/20ml, Infusionslösung"/>
      <target>
        <code value="58606001"/>
        <display value="Primary immune deficiency disorder (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
      <target>
        <code value="33286000"/>
        <display value="Secondary immune deficiency disorder (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
    </element>
    <element>
      <code value="66332-02"/>
      <display value="Iqymune 5g/50ml, Infusionslösung"/>
      <target>
        <code value="58606001"/>
        <display value="Primary immune deficiency disorder (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
      <target>
        <code value="33286000"/>
        <display value="Secondary immune deficiency disorder (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
    </element>
    <element>
      <code value="57469-01"/>
      <display value="Kiovig, Infusionslösung"/>
      <target>
        <code value="58606001"/>
        <display value="Primary immune deficiency disorder (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
      <target>
        <code value="33286000"/>
        <display value="Secondary immune deficiency disorder (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
    </element>
    <element>
      <code value="60323-01"/>
      <display value="Octagam 10 %, Lösung zur intravenösen Anwendung"/>
      <target>
        <code value="58606001"/>
        <display value="Primary immune deficiency disorder (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
      <target>
        <code value="33286000"/>
        <display value="Secondary immune deficiency disorder (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
    </element>
    <element>
      <code value="58314-01"/>
      <display value="Privigen, Infusionslösung"/>
      <target>
        <code value="58606001"/>
        <display value="Primary immune deficiency disorder (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
      <target>
        <code value="33286000"/>
        <display value="Secondary immune deficiency disorder (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
    </element>
    <element>
      <code value="53609-02"/>
      <display value="Rhophylac 300, Injektionslösung"/>
      <target>
        <code value="165746003"/>
        <display value="RhD negative (finding)"/>
        <equivalence value="relatedto"/>
      </target>
    </element>
    <element>
      <code value="65695-02"/>
      <display value="Synagis 100 mg/1 ml, Injektionslösung"/>
      <target>
        <code value="55735004"/>
        <display value="Respiratory syncytial virus infection (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
    </element>
    <element>
      <code value="65695-01"/>
      <display value="Synagis 50 mg/0.5 ml, Injektionslösung"/>
      <target>
        <code value="55735004"/>
        <display value="Respiratory syncytial virus infection (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
    </element>
    <element>
      <code value="00673-02"/>
      <display value="Tetagam P, Injektionslösung"/>
      <target>
        <code value="76902006"/>
        <display value="Tetanus (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
    </element>
    <element>
      <code value="59374-01"/>
      <display value="Uman Big 180 UI/1 ml, solution pour injection intramusculaire"/>
      <target>
        <code value="66071002"/>
        <display value="Viral hepatitis type B (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
    </element>
    <element>
      <code value="59374-02"/>
      <display value="Uman Big 540 UI/3 ml, solution pour injection intramusculaire"/>
      <target>
        <code value="66071002"/>
        <display value="Viral hepatitis type B (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
    </element>
    <element>
      <code value="59451-01"/>
      <display value="Varitect CP, Lösung zur intravenösen Injektion"/>
      <target>
        <code value="38907003"/>
        <display value="Varicella (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
    </element>
    <element>
      <code value="59373-02"/>
      <display value="Venbig 2500 U.I/50 ml, poudre et solution pour injection intraveineuse"/>
      <target>
        <code value="66071002"/>
        <display value="Viral hepatitis type B (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
    </element>
    <element>
      <code value="59373-01"/>
      <display value="Venbig 500 U.I/10 ml, poudre et solution pour injection intraveineuse"/>
      <target>
        <code value="66071002"/>
        <display value="Viral hepatitis type B (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
    </element>
    <element>
      <code value="68471-01"/>
      <display value="Xevudy, Konzentrat zur Herstellung einer Infusionslösung"/>
      <target>
        <code value="840539006"/>
        <display value="Disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
    </element>
    <element>
      <code value="66344-01"/>
      <display value="Zinplava, Konzentrat zur Herstellung einer Infusionslösung"/>
      <target>
        <code value="56688005"/>
        <display value="Clostridial infection (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
    </element>
    <element>
      <code value="61639-01"/>
      <display value="Zutectra, Injektionslösung"/>
      <target>
        <code value="66071002"/>
        <display value="Viral hepatitis type B (disorder)"/>
        <equivalence value="relatedto"/>
      </target>
    </element>
  </group>
</ConceptMap>